UBS Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,725
| Closed | -$3.58K | – | 10307 |
|
|
2023
Q2 | $3.58K | Buy |
3,725
+322
| +9% | +$318 | ﹤0.01% | 7617 |
|
|
2023
Q1 | $2.55K | Sell |
3,403
-298
| -8% | -$217 | ﹤0.01% | 8490 |
|
|
2022
Q4 | $1.37K | Buy |
3,701
+1,508
| +69% | +$636 | ﹤0.01% | 9887 |
|
|
2022
Q3 | $1K | Buy |
2,193
+36
| +2% | +$35 | ﹤0.01% | 10168 |
|
|
2022
Q2 | $2K | Hold |
2,157
| – | – | ﹤0.01% | 9705 |
|
|
2022
Q1 | $3K | Hold |
2,157
| – | – | ﹤0.01% | 9545 |
|
|
2021
Q4 | $3K | Sell |
2,157
-942,812
| -100% | -$1.69M | ﹤0.01% | 9733 |
|
|
2021
Q3 | $2.06M | Buy |
944,969
+834,596
| +756% | +$2.28M | ﹤0.01% | 3546 |
|
|
2021
Q2 | $414K | Sell |
110,373
-201,877
| -65% | -$702K | ﹤0.01% | 4875 |
|
|
2021
Q1 | $1.02M | Buy |
312,250
+306,705
| +5,531% | +$1.1M | ﹤0.01% | 4221 |
|
|
2020
Q4 | $19K | Buy |
5,545
+1,108
| +25% | +$4.56K | ﹤0.01% | 6999 |
|
|
2020
Q3 | $18K | Sell |
4,437
-523
| -11% | -$1.99K | ﹤0.01% | 6412 |
|
|
2020
Q2 | $17K | Sell |
4,960
-34,778
| -88% | -$101K | ﹤0.01% | 6669 |
|
|
2020
Q1 | $93K | Buy |
39,738
+5,594
| +16% | +$15.3K | ﹤0.01% | 5352 |
|
|
2019
Q4 | $124K | Sell |
34,144
-146,739
| -81% | -$1.19M | ﹤0.01% | 5894 |
|
|
2019
Q3 | $1.5M | Buy |
180,883
+175,789
| +3,451% | +$1.42M | ﹤0.01% | 3591 |
|
|
2019
Q2 | $44K | Sell |
5,094
-494
| -9% | -$4.42K | ﹤0.01% | 6041 |
|
|
2019
Q1 | $60K | Sell |
5,588
-201,168
| -97% | -$2.15M | ﹤0.01% | 5424 |
|
|
2018
Q4 | $1.81M | Sell |
206,756
-98,562
| -32% | -$1.26M | ﹤0.01% | 3130 |
|
|
2018
Q3 | $5.13M | Buy |
305,318
+303,230
| +14,523% | +$6.56M | ﹤0.01% | 2325 |
|
|
2018
Q2 | $44K | Sell |
2,088
-258,220
| -99% | -$4.78M | ﹤0.01% | 6085 |
|
|
2018
Q1 | $4.19M | Buy |
260,308
+196,447
| +308% | +$3.89M | ﹤0.01% | 2474 |
|
|
2017
Q4 | $1.21M | Sell |
63,861
-76,157
| -54% | -$1.38M | ﹤0.01% | 3614 |
|
|
2017
Q3 | $1.97M | Buy |
140,018
+47,174
| +51% | +$427K | ﹤0.01% | 3140 |
|
|
2017
Q2 | $691K | Buy |
92,844
+38,626
| +71% | +$252K | ﹤0.01% | 3886 |
|
|
2017
Q1 | $353K | Buy |
54,218
+14,519
| +37% | +$81.2K | ﹤0.01% | 4277 |
|
|
2016
Q4 | $176K | Sell |
39,699
-29,789
| -43% | -$125K | ﹤0.01% | 4895 |
|
|
2016
Q3 | $325K | Sell |
69,488
-29,829
| -30% | -$177K | ﹤0.01% | 4207 |
|
|
2016
Q2 | $652K | Buy |
99,317
+58,413
| +143% | +$413K | ﹤0.01% | 3711 |
|
|
2016
Q1 | $260K | Sell |
40,904
-184,705
| -82% | -$948K | ﹤0.01% | 4309 |
|
|
2015
Q4 | $1.36M | Buy |
225,609
+163,898
| +266% | +$937K | ﹤0.01% | 3154 |
|
|
2015
Q3 | $369K | Buy |
61,711
+56,545
| +1,095% | +$393K | ﹤0.01% | 4146 |
|
|
2015
Q2 | $35K | Sell |
5,166
-175
| -3% | -$1.11K | ﹤0.01% | 6343 |
|
|
2015
Q1 | $32K | Buy |
5,341
+127
| +2% | +$845 | ﹤0.01% | 6491 |
|
|
2014
Q4 | $37K | Buy |
+5,214
| New | +$38.3K | ﹤0.01% | 6871 |
|
UBS Group's SPPI Position: Q3 2023 in Review
UBS Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 3,725 shares — an estimated $3.58K sold.
UBS Group first reported a position in SPPI in Q4 2014 and held it in 35 quarters. The position peaked at $5.13M in Q3 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- UBS Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- UBS Group sold 3,725 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $3.58K.
- UBS Group first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 35 quarters.
- UBS Group's Spectrum Pharmaceuticals Inc position peaked at $5.13M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.